Vanda Pharmaceuticals
VNDA
VNDA
180 hedge funds and large institutions have $947M invested in Vanda Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 60 increasing their positions, 74 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
180
Holders Change
+1
Holders Change %
+0.56%
% of All Funds
3.16%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
60
Reduced
74
Closed
15
Calls
$2.07M
Puts
$2.57M
Net Calls
-$502K
Net Calls Change
-$835K
Top Buyers
| 1 |
Nuveen Asset Management
Chicago,
Illinois
|
$14.1M |
| 2 |
Millennium Management
New York
|
$10.4M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
$5.12M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
$36.5M |
| 5 |
State Street
Boston,
Massachusetts
|
$58.2M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
$33.7M |
| 2 |
Morgan Stanley
New York
|
$4.25M |
| 3 |
PIM
Profit Investment Management
North Bethesda,
Maryland
|
$1.34M |
| 4 |
BlackRock
New York
|
$166M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$1.5M |
